ChartMill assigns a Buy % Consensus number of 43% to AMTI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-28 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2023-03-06 | Chardan Capital | Reiterate | Buy |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2023-01-05 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-12-27 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-12-23 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-12-02 | Chardan Capital | Initiate | Buy |
| 2022-11-08 | SVB Leerink | Maintains | Outperform |
| 2022-07-07 | Jefferies | Downgrade | Buy -> Hold |
| 2022-05-20 | SVB Leerink | Maintains | Outperform |
| 2022-05-19 | JMP Securities | Maintains | Market Outperform |
| 2022-05-10 | SVB Leerink | Maintains | Outperform |
| 2021-03-17 | JMP Securities | Initiate | Outperform |
| 2021-02-22 | SVB Leerink | Maintains | Outperform |
6 analysts have analysed AMTI and the average price target is 1.02 USD. This implies a price increase of 287.83% is expected in the next year compared to the current price of 0.263.
The consensus rating for APPLIED MOLECULAR TRANSPORT (AMTI) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.